immuno-oncology - gestinad€¦ · immuno-oncology asco review 21 y 22 de septiembre de 2017 madrid...
TRANSCRIPT
W H A T ´ S C O M I N G I N
IMMUNO-ONCOLOGYASCO review
21 y 22 de septiembre de 2017Madrid
Con el aval científico de:
COORDINADORES
Patrocinadores
Hilario Mata, PhD, MBA.Director of Global Academic
Programs at the University of TexasM.D. Anderson Cancer Center.
TBD
15:30 - 16:00 CAFÉ BIENVENIDA / WELCOME COFFEE
16:00 - 16:10 BIENVENIDA / WELCOME
Moderadores - ChairpersonsTBD
16:10 - 16:40 Resumen ASCO en Cáncer Renal - ASCO Summary in Renal Cancer TBD
16:40 - 17:10 Ponencia - Speech José A. Karam, MD, FACS. Department of Urology, Division of Surgery. MD Anderson Cancer Center, Houston.
17:10 - 17:30 Pipeline Industria farmacéutica TBD
17:30 - 18:00 DEBATE / Q&A
18:00 - 18:15 CIERRE / CLOSURE
Moderadores - ChairpersonsTBD
9:00 - 9:30 Resumen ASCO en Melanoma - ASCO Summary in Melanoma TBD
9:30 - 10:10 Ponencia - Speech Michael A. Davies, MD, PhD. Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston.
10:10 - 10:30 Pipeline Industria farmacéutica TBD
10:30 - 11:00 DEBATE / Q&A
11:00 - 11:30 PAUSA CAFÉ / COFFEE BREAK
Moderadores - ChairpersonsTBD
11:30 - 12:00 Resumen ASCO en Cáncer de Mama - ASCO Summary in Breast Cancer TBD
12:00 - 12:30 Ponencia - Speech Vicente Valero, MD, F.A.C.P. Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston.
12:30 - 12:45 Pipeline Industria farmacéutica TBD
12:45 - 13:15 DEBATE / Q&A
13:15 - 14:30 PAUSA ALMUERZO / LUNCH BREAK
Moderadores - ChairpersonsTBD
14:30 - 15:00 Resumen ASCO en Cáncer de Pulmón - ASCO Summary in Lung Cancer TBD
15:00 - 15:40 Ponencia - Speech George Simon, MD, FACP, FCCP. Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston.
15:40 - 16:00 Pipeline industria farmacéutica TBD
16:00 - 16:30 DEBATE / Q&A
16:30 - 16:45 PAUSA CAFÉ / COFFEE BREAK
Moderadores - ChairpersonsTBD
16:45 - 17:15 Resumen ASCO en Cáncer Colorrectal - ASCO Summary in Colorectal Cancer TBD
17:15 - 18:00 Ponencia - Speech TBD
18:00 - 18:15 Pipeline Industria farmacéutica TBD
18:15 - 18:45 DEBATE / Q&A
18:45 - 19:00 CIERRE / CLOSURE
ASCO review
J U E V E S 2 1
V I E R N E S 2 2
16:1
0- 1
8:00
CÁN
CER
REN
AL -
REN
AL C
ANCE
R
9:00
- 11
:00
M
ELAN
OM
A14
:30
- 16:
30CÁ
NCE
R DE
PU
LMÓ
NLU
NG
CAN
CER
16:4
5 - 1
8:45
CÁN
CER
COLO
RREC
TAL
COLO
RECT
AL C
ANCE
R
11:3
0 - 1
3:15
CÁN
CER
DE M
AMA
BREA
ST C
ANCE
R
PROGRAMA
José A. Karam, MD, FACS. Department of Urology, Division of Surgery. MD Anderson Cancer Center, Houston. Associate Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
Administrative Appointments/Responsibilities Member, Cancer Education Committee - Genitourinary Cancer Track, American Society of Clinical Oncology (ASCO), Alexandria, VA, 6/2013-5/2016. Ex Officio Member, AACR Clinical and Translational Research Committee, Philadelphia, PA, 2010-2012. Member, Associate Member Council, American Association of Cancer Research, Philadelphia, PA, 2008-2011.
George Simon, MD, FACP, FCCP. Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston. Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Chief, Section of Experimental Therapeutics, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
TBD
Michael A. Davies, MD, PhD. Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston. Associate Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Deputy Chair, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Co-Leader of Melanoma Moon Shot Program, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, TX. Director of Research Activities, Hematology/Oncology Fellowship Program, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Vicente Valero, MD, F.A.C.P. Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston. Deputy Chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
ASCO review21 y 22 de septiembre de 2017
Hilario Mata, PhD, MBA.Director of Global AcademicPrograms at the University of TexasM.D. Anderson Cancer Center.
TBD
CÁNCER RENAL - RENAL CANCER
CÁNCER DE MAMA - BREAST CANCER
CÁNCER COLORRECTAL - COLORECTAL CANCER
CÁNCER DE PULMÓN - LUNG CANCER
MELANOMA
PONENTES
COORDINADORES
J U E V E S 2 1
V I E R N E S 2 2